CD8A and malaria: Thus, applying this approach in human malaria may both uncover new vaccine targets and help us down‐select vaccine candidates that are more likely to drive robust antibody responses through TFH restimulation and long‐lasting CD8 T‐cell memory differentiation through DC‐integrated CD4 help.